It is not known if DUPIXENT is safe and effective in children with atopic dermatitis under 6 months of age. with other asthma medicines for the maintenance treatment of moderate-to-severe ...

Sanofi is buying an immunology drug from Dren Bio, Inc. for up to $1.9 billion, in a deal it said will help it become a ...

Currently, their treatment options are ... like atopic dermatitis and eosinophilic asthma. The other is chronic spontaneous urticaria (CSU), for which Dupixent was turned down in 2023 but refiled ...

Regeneron Pharmaceuticals, Inc. faces Eylea revenue decline but shows growth potential with Dupixent & Libtayo. Click for ...

You should not receive a “live vaccine” right before and during treatment with DUPIXENT. are pregnant ... or inhaled corticosteroid medicines; have asthma and use an asthma medicine; or ...

“Data on the efficacy and durability of biologic treatments ... with asthma who received an approved biologic therapy — omalizumab (Xolair; Genentech, Novartis), dupilumab (Dupixent; Sanofi ...

n=3), asthma (n=4 vs. n=1), conjunctivitis ... You should not receive a “live vaccine” right before and during treatment with DUPIXENT. are pregnant or plan to become pregnant.

Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoid If approved, Dupixent would be the first and only targeted medicine to treat BP in the US; FDA ...

n=3), asthma (n=4 vs. n=1), conjunctivitis (n=4 vs ... You should not receive a “live vaccine” right before and during treatment with DUPIXENT. are pregnant or plan to become pregnant. It is not known ...